Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A large multisite cancer family is linked to BRCA2.
Tonin P, Ghadirian P, Phelan C, Lenoir GM, Lynch HT, Letendre F, Belanger D, Monté M, Narod SA. Tonin P, et al. Among authors: belanger d. J Med Genet. 1995 Dec;32(12):982-4. doi: 10.1136/jmg.32.12.982. J Med Genet. 1995. PMID: 8825930 Free PMC article.
Hereditary breast cancer in 19 females and 2 males: Kindred, P.G. 1940.
Ghadirian P, Narod S, Perret C, Lambert DM, Latreille J, Letendre F, Monté M, Belanger D. Ghadirian P, et al. Among authors: belanger d. Eur J Cancer. 1995;31A(2):284-7. doi: 10.1016/0959-8049(94)00471-g. Eur J Cancer. 1995. PMID: 7718340 No abstract available.
Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect.
Le Blanc R, Montminy-Métivier S, Bélanger R, Busque L, Fish D, Roy DC, Kassis J, Boileau J, Lavallée R, Bélanger D, Letendre F, Hébert J, Sauvageau G, Perreault C, Roy J. Le Blanc R, et al. Among authors: belanger r, belanger d. Bone Marrow Transplant. 2001 Nov;28(9):841-8. doi: 10.1038/sj.bmt.1703253. Bone Marrow Transplant. 2001. PMID: 11781644 Review.
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy.
Cantin G, L'Espérance B, Yelle L, Desjardins L, Couture F, Bergeron M, Lacroix L, Dufresne J, Bélanger D, Ouellet PA, Hewitt LA, Pirc L, Gyger M. Cantin G, et al. Among authors: belanger d. Cancer Chemother Pharmacol. 1999;43(6):503-6. doi: 10.1007/s002800050930. Cancer Chemother Pharmacol. 1999. PMID: 10321511 Clinical Trial.
222 results